OSPREY MEDICAL INC - Announcements

0.00%

20.0¢

Currently unlisted.

Osprey Medical, Inc. is a commercial stage company, which is focused on protecting... Osprey Medical, Inc. is a commercial stage company, which is focused on protecting patients from the harmful effects of X-ray dye (contrast) used during commonly performed angiographic imaging procedures. The Company’s products include AVERT, AVERT Plus, the DyeVert NG, DyeVert Plus, and DyeVert Plus EZ Systems. The AVERT Plus System reduces and monitors the amount of contrast dye used in commonly performed heart and peripheral vascular procedures. The DyeVert System is a self-adjusting product that reduces the amount of contrast dye used in commonly performed heart and peripheral procedures. DyeVert interfaces with syringe-manifold systems. These technologies are available with the United States Food and Drug Administration cleared indication for dye volume reduction. Its dye reduction and monitoring technologies are designed to help physicians minimize dye usage and reduce kidney damage associated with the use of contrast media for common cardiovascular procedures.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

OSP	Half Yearly Accounts Report		21/08/17	187.88KB	Share
OSP	Appendix 4D Half Year Report & Accounts	PRICE SENSITIVE	21/08/17	207.47KB	Share
OSP	Appendix 3B		18/08/17	186.29KB	Share
OSP	Amended and Restated Certificate of Incorporation		16/08/17	1.07MB	Share
OSP	Notice to Nominees		15/08/17	587.23KB	Share
OSP	Substantial Holder Notice		14/08/17	85.71KB	Share
OSP	Substantial Holder Notice		14/08/17	232.05KB	Share
OSP	Change in substantial holding		14/08/17	85.56KB	Share
OSP	Notice of despatch of entitlement offer documents		14/08/17	1010.4KB	Share
OSP	Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)		11/08/17	130.56KB	Share
OSP	Cleansing Statement		11/08/17	118.05KB	Share
OSP	Appendix 3B		11/08/17	199.49KB	Share
OSP	Private Placement Update	PRICE SENSITIVE	11/08/17	97.6KB	Share
OSP	Entitlement Offer - notification to ineligible CDI holders		07/08/17	625.16KB	Share
OSP	Entitlement Offer - notice to holders of CDIs		07/08/17	545.87KB	Share
OSP	Entitlement Offer - Notice to Optionholders		04/08/17	108.93KB	Share
OSP	Appendix 3B		04/08/17	192.22KB	Share
OSP	Cleansing Statement - Rights Issue		04/08/17	177.89KB	Share
OSP	Investor Presentation		04/08/17	3.17MB	Share
OSP	Entitlement Offer Booklet	PRICE SENSITIVE	04/08/17	372.17KB	Share
OSP	Over-subscribed placement and underwritten entitlement offer	PRICE SENSITIVE	04/08/17	145.92KB	Share
OSP	Trading Halt	PRICE SENSITIVE	02/08/17	333.8KB	Share
OSP	CommSec Interview with CEO Mike McCormick		28/07/17	433.38KB	Share
OSP	Osprey Medical July 2017 Investor Newsletter		19/07/17	2.28MB	Share
OSP	CEO Company Update Presentation		17/07/17	3.22MB	Share
OSP	Appendix 4C	PRICE SENSITIVE	13/07/17	1.31MB	Share
OSP	Osprey Medical Increases Addressable Market	PRICE SENSITIVE	03/07/17	1.16MB	Share
OSP	Appendix 3X		20/06/17	99.28KB	Share
OSP	Medtronic VP and GM Sandra Lesenfants Joins Osprey Board		20/06/17	137.38KB	Share
OSP	Appendix 3B		19/06/17	175.27KB	Share
OSP	Appendix 3B		23/05/17	178.19KB	Share
OSP	Appendix 3Y		22/05/17	131.69KB	Share
OSP	Appendix 3Y		22/05/17	131.2KB	Share
OSP	Appendix 3Y		22/05/17	131.27KB	Share
OSP	Annual Meeting Results		18/05/17	136.8KB	Share
OSP	Chairman's Address and CEO's Presentation at Annual Meeting		18/05/17	5.32MB	Share
OSP	Osprey Presentation		15/05/17	4.87MB	Share
OSP	Notice of Annual Meeting of Stockholders		24/04/17	962.95KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	18/04/17	1.54MB	Share
OSP	Appendix 3B		31/03/17	214.14KB	Share
OSP	2016 Annual Report		27/03/17	673.83KB	Share
OSP	Appendix 4G and Corporate Governance Statement		27/03/17	525.82KB	Share
OSP	CEO Presentation		20/03/17	3.75MB	Share
OSP	Osprey Medical March 2017 Investor Newsletter		09/03/17	2.13MB	Share
OSP	Osprey Medical Receives US FDA Clearance for DyeVert PLUS	PRICE SENSITIVE	09/03/17	371.4KB	Share
OSP	Preliminary Final Report and Consolidated Financial Accounts	PRICE SENSITIVE	27/02/17	295.79KB	Share
OSP	Appendix 3B		21/02/17	215.46KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	30/01/17	1.62MB	Share
OSP	Appendix 3B		18/01/17	214.89KB	Share
OSP	CEO Presentation		06/12/16	1.86MB	Share
OSP	Osprey November 2016 Investor Newsletter		21/11/16	2.01MB	Share
OSP	Becoming a substantial holder		08/11/16	131.91KB	Share
OSP	Osprey Introduces DyeVert PLUS at TCT-OSP.AX	PRICE SENSITIVE	02/11/16	370.42KB	Share
OSP	Osprey to present at TCT 2016-OSP.AX		26/10/16	288.1KB	Share
OSP	CEO Presentation-OSP.AX		21/10/16	2.11MB	Share
OSP	Appendix 4C-OSP.AX	PRICE SENSITIVE	14/10/16	1.58MB	Share
OSP	Appendix 3B-OSP.AX		19/09/16	211.98KB	Share
OSP	Appendix 3Y-OSP.AX		14/09/16	129.35KB	Share
OSP	Change in substantial holding-OSP.AX		12/09/16	156.54KB	Share
OSP	Appendix 3B-OSP.AX		12/09/16	219.91KB	Share
OSP	Substantial Shareholder Notice-OSP.AX		09/09/16	321.54KB	Share
OSP	Substantial Shareholder Notice-OSP.AX		09/09/16	330.56KB	Share
OSP	Substantial Shareholder Notice-OSP.AX		09/09/16	213.39KB	Share
OSP	Notice given under Section 708A(5)(e)-OSP.AX		09/09/16	114.07KB	Share
OSP	Appendix 3B-OSP.AX		09/09/16	219.35KB	Share
OSP	Completion of Private Placement-OSP.AX		09/09/16	91.54KB	Share
OSP	SECURITY PURCHASE PLAN SCALE BACK-OSP.AX		07/09/16	106.58KB	Share
OSP	Notice given under Section 708A(5)(e)-OSP.AX		06/09/16	114.11KB	Share
OSP	Appendix 3B-OSP.AX		06/09/16	212.84KB	Share
OSP	Partial Allocation Under Tranche 2 of Placement and SPP-OSP.AX		06/09/16	105.71KB	Share
OSP	Results of Special Meeting of Stockholders-OSP.AX		30/08/16	133.21KB	Share
OSP	Half Year Accounts Report-OSP.AX		29/08/16	518.72KB	Share
OSP	Appendix 4D Half Year Report & Accounts-OSP.AX	PRICE SENSITIVE	29/08/16	198.66KB	Share
OSP	Change in substantial holding-OSP.AX		19/08/16	258KB	Share
OSP	Notice of Special Meeting of Stockholders and Proxy Forms-OSP.AX		18/08/16	451.91KB	Share
OSP	Substantial Shareholder Notice-OSP.AX		16/08/16	390.85KB	Share
OSP	Share Purchase Plan-OSP.AX		15/08/16	617.25KB	Share
OSP	Substantial Shareholder Notice-OSP.AX		11/08/16	540.8KB	Share
OSP	Substanital Shareholder Notice-OSP.AX		11/08/16	538.19KB	Share
OSP	Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)-OSP.AX		11/08/16	103.43KB	Share
OSP	Appendix 3B-OSP.AX		11/08/16	213.56KB	Share
OSP	Cleansing Statement-OSP.AX		11/08/16	117.61KB	Share
OSP	Revised CEO Capital Raising Presentation-OSP.AX		04/08/16	1.75MB	Share
OSP	Amended and Restated Certificate of Incorporation-OSP.AX		04/08/16	1.01MB	Share
OSP	CEO Capital Raising Presentation-OSP.AX		04/08/16	5.13MB	Share
OSP	Osprey - Oversubscribed A$28 Million Private Placement-OSP.AX	PRICE SENSITIVE	04/08/16	123.62KB	Share
OSP	Trading Halt-OSP.AX	PRICE SENSITIVE	02/08/16	357.91KB	Share
OSP	Response to ASX Price Query-OSP.AX	PRICE SENSITIVE	29/07/16	500.07KB	Share
OSP	CommSec Interview with CEO Mike McCormick-OSP.AX		27/07/16	205.59KB	Share
OSP	Appendix 4C - quarterly-OSP.AX	PRICE SENSITIVE	20/07/16	804.55KB	Share
OSP	Osprey Medical Inc - Q2 Key Sales Milestones-OSP.AX	PRICE SENSITIVE	07/07/16	107.78KB	Share
OSP	Osprey June 2016 Investor Newsletter-OSP.AX		06/06/16	1.88MB	Share
OSP	Appendix 3B-OSP.AX		25/05/16	211.28KB	Share
OSP	DyeVert Pilot Trial Results Presented at EuroPCR-OSP.AX		20/05/16	215.23KB	Share
OSP	Appendix 3Y-OSP.AX		18/05/16	125.87KB	Share
OSP	Annual Meeting Results-OSP.AX		12/05/16	134.27KB	Share
OSP	Chairman's Address and CEO's Presentation at Annual Meeting-OSP.AX		12/05/16	5.14MB	Share
OSP	AVERT Trial Results Presented at SCAI-OSP.AX	PRICE SENSITIVE	09/05/16	236.14KB	Share
OSP	Clinical Trial Results Presentation-OSP.AX		09/05/16	2.21MB	Share
OSP	Osprey Technology at Cardiovascular Meeting-OSP.AX		26/04/16	335.43KB	Share

OSP Half Yearly Accounts Report
21/08/17		187.88KB	Share
OSP Appendix 4D Half Year Report & Accounts
21/08/17	PRICE SENSITIVE	207.47KB	Share
OSP Appendix 3B
18/08/17		186.29KB	Share
OSP Amended and Restated Certificate of Incorporation
16/08/17		1.07MB	Share
OSP Notice to Nominees
15/08/17		587.23KB	Share
OSP Substantial Holder Notice
14/08/17		85.71KB	Share
OSP Substantial Holder Notice
14/08/17		232.05KB	Share
OSP Change in substantial holding
14/08/17		85.56KB	Share
OSP Notice of despatch of entitlement offer documents
14/08/17		1010.4KB	Share
OSP Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)
11/08/17		130.56KB	Share
OSP Cleansing Statement
11/08/17		118.05KB	Share
OSP Appendix 3B
11/08/17		199.49KB	Share
OSP Private Placement Update
11/08/17	PRICE SENSITIVE	97.6KB	Share
OSP Entitlement Offer - notification to ineligible CDI holders
07/08/17		625.16KB	Share
OSP Entitlement Offer - notice to holders of CDIs
07/08/17		545.87KB	Share
OSP Entitlement Offer - Notice to Optionholders
04/08/17		108.93KB	Share
OSP Appendix 3B
04/08/17		192.22KB	Share
OSP Cleansing Statement - Rights Issue
04/08/17		177.89KB	Share
OSP Investor Presentation
04/08/17		3.17MB	Share
OSP Entitlement Offer Booklet
04/08/17	PRICE SENSITIVE	372.17KB	Share
OSP Over-subscribed placement and underwritten entitlement offer
04/08/17	PRICE SENSITIVE	145.92KB	Share
OSP Trading Halt
02/08/17	PRICE SENSITIVE	333.8KB	Share
OSP CommSec Interview with CEO Mike McCormick
28/07/17		433.38KB	Share
OSP Osprey Medical July 2017 Investor Newsletter
19/07/17		2.28MB	Share
OSP CEO Company Update Presentation
17/07/17		3.22MB	Share
OSP Appendix 4C
13/07/17	PRICE SENSITIVE	1.31MB	Share
OSP Osprey Medical Increases Addressable Market
03/07/17	PRICE SENSITIVE	1.16MB	Share
OSP Appendix 3X
20/06/17		99.28KB	Share
OSP Medtronic VP and GM Sandra Lesenfants Joins Osprey Board
20/06/17		137.38KB	Share
OSP Appendix 3B
19/06/17		175.27KB	Share
OSP Appendix 3B
23/05/17		178.19KB	Share
OSP Appendix 3Y
22/05/17		131.69KB	Share
OSP Appendix 3Y
22/05/17		131.2KB	Share
OSP Appendix 3Y
22/05/17		131.27KB	Share
OSP Annual Meeting Results
18/05/17		136.8KB	Share
OSP Chairman's Address and CEO's Presentation at Annual Meeting
18/05/17		5.32MB	Share
OSP Osprey Presentation
15/05/17		4.87MB	Share
OSP Notice of Annual Meeting of Stockholders
24/04/17		962.95KB	Share
OSP Appendix 4C
18/04/17	PRICE SENSITIVE	1.54MB	Share
OSP Appendix 3B
31/03/17		214.14KB	Share
OSP 2016 Annual Report
27/03/17		673.83KB	Share
OSP Appendix 4G and Corporate Governance Statement
27/03/17		525.82KB	Share
OSP CEO Presentation
20/03/17		3.75MB	Share
OSP Osprey Medical March 2017 Investor Newsletter
09/03/17		2.13MB	Share
OSP Osprey Medical Receives US FDA Clearance for DyeVert PLUS
09/03/17	PRICE SENSITIVE	371.4KB	Share
OSP Preliminary Final Report and Consolidated Financial Accounts
27/02/17	PRICE SENSITIVE	295.79KB	Share
OSP Appendix 3B
21/02/17		215.46KB	Share
OSP Appendix 4C
30/01/17	PRICE SENSITIVE	1.62MB	Share
OSP Appendix 3B
18/01/17		214.89KB	Share
OSP CEO Presentation
06/12/16		1.86MB	Share
OSP Osprey November 2016 Investor Newsletter
21/11/16		2.01MB	Share
OSP Becoming a substantial holder
08/11/16		131.91KB	Share
OSP Osprey Introduces DyeVert PLUS at TCT-OSP.AX
02/11/16	PRICE SENSITIVE	370.42KB	Share
OSP Osprey to present at TCT 2016-OSP.AX
26/10/16		288.1KB	Share
OSP CEO Presentation-OSP.AX
21/10/16		2.11MB	Share
OSP Appendix 4C-OSP.AX
14/10/16	PRICE SENSITIVE	1.58MB	Share
OSP Appendix 3B-OSP.AX
19/09/16		211.98KB	Share
OSP Appendix 3Y-OSP.AX
14/09/16		129.35KB	Share
OSP Change in substantial holding-OSP.AX
12/09/16		156.54KB	Share
OSP Appendix 3B-OSP.AX
12/09/16		219.91KB	Share
OSP Substantial Shareholder Notice-OSP.AX
09/09/16		321.54KB	Share
OSP Substantial Shareholder Notice-OSP.AX
09/09/16		330.56KB	Share
OSP Substantial Shareholder Notice-OSP.AX
09/09/16		213.39KB	Share
OSP Notice given under Section 708A(5)(e)-OSP.AX
09/09/16		114.07KB	Share
OSP Appendix 3B-OSP.AX
09/09/16		219.35KB	Share
OSP Completion of Private Placement-OSP.AX
09/09/16		91.54KB	Share
OSP SECURITY PURCHASE PLAN SCALE BACK-OSP.AX
07/09/16		106.58KB	Share
OSP Notice given under Section 708A(5)(e)-OSP.AX
06/09/16		114.11KB	Share
OSP Appendix 3B-OSP.AX
06/09/16		212.84KB	Share
OSP Partial Allocation Under Tranche 2 of Placement and SPP-OSP.AX
06/09/16		105.71KB	Share
OSP Results of Special Meeting of Stockholders-OSP.AX
30/08/16		133.21KB	Share
OSP Half Year Accounts Report-OSP.AX
29/08/16		518.72KB	Share
OSP Appendix 4D Half Year Report & Accounts-OSP.AX
29/08/16	PRICE SENSITIVE	198.66KB	Share
OSP Change in substantial holding-OSP.AX
19/08/16		258KB	Share
OSP Notice of Special Meeting of Stockholders and Proxy Forms-OSP.AX
18/08/16		451.91KB	Share
OSP Substantial Shareholder Notice-OSP.AX
16/08/16		390.85KB	Share
OSP Share Purchase Plan-OSP.AX
15/08/16		617.25KB	Share
OSP Substantial Shareholder Notice-OSP.AX
11/08/16		540.8KB	Share
OSP Substanital Shareholder Notice-OSP.AX
11/08/16		538.19KB	Share
OSP Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)-OSP.AX
11/08/16		103.43KB	Share
OSP Appendix 3B-OSP.AX
11/08/16		213.56KB	Share
OSP Cleansing Statement-OSP.AX
11/08/16		117.61KB	Share
OSP Revised CEO Capital Raising Presentation-OSP.AX
04/08/16		1.75MB	Share
OSP Amended and Restated Certificate of Incorporation-OSP.AX
04/08/16		1.01MB	Share
OSP CEO Capital Raising Presentation-OSP.AX
04/08/16		5.13MB	Share
OSP Osprey - Oversubscribed A$28 Million Private Placement-OSP.AX
04/08/16	PRICE SENSITIVE	123.62KB	Share
OSP Trading Halt-OSP.AX
02/08/16	PRICE SENSITIVE	357.91KB	Share
OSP Response to ASX Price Query-OSP.AX
29/07/16	PRICE SENSITIVE	500.07KB	Share
OSP CommSec Interview with CEO Mike McCormick-OSP.AX
27/07/16		205.59KB	Share
OSP Appendix 4C - quarterly-OSP.AX
20/07/16	PRICE SENSITIVE	804.55KB	Share
OSP Osprey Medical Inc - Q2 Key Sales Milestones-OSP.AX
07/07/16	PRICE SENSITIVE	107.78KB	Share
OSP Osprey June 2016 Investor Newsletter-OSP.AX
06/06/16		1.88MB	Share
OSP Appendix 3B-OSP.AX
25/05/16		211.28KB	Share
OSP DyeVert Pilot Trial Results Presented at EuroPCR-OSP.AX
20/05/16		215.23KB	Share
OSP Appendix 3Y-OSP.AX
18/05/16		125.87KB	Share
OSP Annual Meeting Results-OSP.AX
12/05/16		134.27KB	Share
OSP Chairman's Address and CEO's Presentation at Annual Meeting-OSP.AX
12/05/16		5.14MB	Share
OSP AVERT Trial Results Presented at SCAI-OSP.AX
09/05/16	PRICE SENSITIVE	236.14KB	Share
OSP Clinical Trial Results Presentation-OSP.AX
09/05/16		2.21MB	Share
OSP Osprey Technology at Cardiovascular Meeting-OSP.AX
26/04/16		335.43KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

OSPREY MEDICAL INC - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available